From automated cannons that literally shred their target to pieces, to extremely agile missile systems, Close-In Weapon Systems are a vessel's last line of defense against anything hostile above the waterline that is danger close. Lasers will eventually take on the majority of this duty, but in the meantime let's…
Learn more about DREADD receptors and their ligands and actuators: CNO (clozapine n-oxide), perlapine, DREADD agonist 21 (Compound 21), J60, J52 and SalB (salvinorin B)
750 million+ members | Manage your professional identity. Build and engage with your professional network. Access knowledge, insights and opportunities.
DESCRIPTION: The Counter-Rocket, Artillery, Mortar (C-RAM) Intercept evolved from the operational success of the C-RAM system-of-systems effort in theater. It transitioned to an acquisition program to provide counter-RAM protection to the Indirect Fire Protection Capability/Avenger Battalions, 5th Battalion 5th Ai ...
Cwiz 100mg Tablet: View Uses, Side Effects, Price and Substitutes | 1mg
Cwiz 100mg Tablet is used in the treatment of Bacterial infections. View Cwiz 100mg Tablet (strip of 10 tablets) uses, composition, side-effects, price, substitutes, drug interactions, precautions, warnings, expert advice and buy online at best price on 1mg.com
Compound 21, a two-edged sword with both DREADD-selective and off-target outcomes in rats
Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) represent a technical revolution in integrative neuroscience. However, the first used ligands exhibited dose-dependent selectivity for their molecular target, leading to potential unspecific effects. Compound 21 (C21) was recently proposed as an alternative, but in vivo characterization of its properties is not sufficient yet. Here, we evaluated its potency to selectively modulate the activity of nigral dopaminergic (DA) neurons through the canonical DREADD receptor hM4Di using TH-Cre rats. In males, 1 mg.kg-1 of C21 strongly increased nigral neurons activity in control animals, indicative of a significant off-target effect. Reducing the dose to 0.5 mg.kg-1 circumvented this unspecific effect, while activated the inhibitory DREADDs and selectively reduced nigral neurons firing. In females, 0.5 mg.kg-1 of C21 induced a transient and residual off-target effect that may mitigated the inhibitory DREADDs-mediated effect. This study raises up the necessity to test selectivity and efficacy of chosen ligands for each new experimental condition.
Gi-DREADD Expression in Peripheral Nerves Produces Ligand-Dependent Analgesia, as well as Ligand-Independent Functional Changes in Sensory Neurons | Journal of Neuroscience
Designer receptors exclusively activated by designer drugs (DREADDs) are an advanced experimental tool that could potentially provide a novel approach to pain management. In particular, expression of an inhibitory (Gi-coupled) DREADD in nociceptors might enable ligand-dependent analgesia. To test this possibility, TRPV1-cre mice were used to restrict expression of Gi-DREADDs to predominantly C-fibers. Whereas baseline heat thresholds in both male and female mice expressing Gi-DREADD were normal, 1 mg/kg clozapine- N -oxide (CNO) produced a significant 3 h increase in heat threshold that returned to baseline by 5 h after injection. Consistent with these behavioral results, CNO decreased action potential firing in isolated sensory neurons from Gi-DREADD mice. Unexpectedly, however, the expression of Gi-DREADD in sensory neurons caused significant changes in voltage-gated Ca2+ and Na+ currents in the absence of CNO, as well as an increase in Na+ channel (NaV1.7) expression. Furthermore, CNO-independent excitatory and inhibitory second-messenger signaling was also altered in these mice, which was associated with a decrease in the analgesic effect of endogenous inhibitory G-protein-coupled receptor activation. These results highlight the potential of this exciting technology, but also its limitations, and that it is essential to identify the underlying mechanisms for any observed behavioral phenotypes. SIGNIFICANCE STATEMENT DREADD technology is a powerful tool enabling manipulation of activity and/or transmitter release from targeted cell populations. The purpose of this study was to determine whether inhibitory DREADDs in nociceptive afferents could be used to produce analgesia, and if so, how. DREADD activation produced a ligand-dependent analgesia to heat in vivo and a decrease in neuronal firing at the single-cell level. However, we observed that expression of Gi-DREADD also causes ligand-independent changes in ion channel activity and second-messenger signaling. These findings highlight both the potential and the limitations of this exciting technology as well as the necessity to identify the mechanisms underlying any observed phenotype.
DJ C Wiz Presents: What Cha Starin' At? Mixtape (Parental Advisory) Song Download: DJ C Wiz Presents: What Cha Starin' At? Mixtape (Parental Advisory) MP3 Song Online Free on Gaana.com
Listen to the song of DJ C Wiz Presents: What Cha Starin' At? Mixtape (Parental Advisory) album on Gaana.com. Enjoy DJ C Wiz Presents: What Cha Starin' At? Mixtape (Parental Advisory) song by Project Pat on Gaana.com.